GB2163647B - Benzoylecgonie or benzoylnorecgonine as active agent for the treatment of rheumatoid arthritis - Google Patents

Benzoylecgonie or benzoylnorecgonine as active agent for the treatment of rheumatoid arthritis

Info

Publication number
GB2163647B
GB2163647B GB08422114A GB8422114A GB2163647B GB 2163647 B GB2163647 B GB 2163647B GB 08422114 A GB08422114 A GB 08422114A GB 8422114 A GB8422114 A GB 8422114A GB 2163647 B GB2163647 B GB 2163647B
Authority
GB
United Kingdom
Prior art keywords
benzoylnorecgonine
benzoylecgonie
treatment
active agent
rheumatoid arthritis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08422114A
Other versions
GB8422114D0 (en
GB2163647A (en
Inventor
Lowell M Somers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB08422114A priority Critical patent/GB2163647B/en
Publication of GB8422114D0 publication Critical patent/GB8422114D0/en
Publication of GB2163647A publication Critical patent/GB2163647A/en
Application granted granted Critical
Publication of GB2163647B publication Critical patent/GB2163647B/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB08422114A 1984-08-31 1984-08-31 Benzoylecgonie or benzoylnorecgonine as active agent for the treatment of rheumatoid arthritis Expired GB2163647B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB08422114A GB2163647B (en) 1984-08-31 1984-08-31 Benzoylecgonie or benzoylnorecgonine as active agent for the treatment of rheumatoid arthritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB08422114A GB2163647B (en) 1984-08-31 1984-08-31 Benzoylecgonie or benzoylnorecgonine as active agent for the treatment of rheumatoid arthritis

Publications (3)

Publication Number Publication Date
GB8422114D0 GB8422114D0 (en) 1984-10-03
GB2163647A GB2163647A (en) 1986-03-05
GB2163647B true GB2163647B (en) 1989-02-01

Family

ID=10566117

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08422114A Expired GB2163647B (en) 1984-08-31 1984-08-31 Benzoylecgonie or benzoylnorecgonine as active agent for the treatment of rheumatoid arthritis

Country Status (1)

Country Link
GB (1) GB2163647B (en)

Also Published As

Publication number Publication date
GB8422114D0 (en) 1984-10-03
GB2163647A (en) 1986-03-05

Similar Documents

Publication Publication Date Title
GB2206788B (en) 5 ht-3 antagonist for the treatment or reduction of dependence
SG61693G (en) Medicaments for the treatment of emesis
ZA857081B (en) Composition for the treatment of allergy
GB2103088B (en) Treatment of arthritis
ZA867530B (en) Composition for the treatment of acne
GB8528846D0 (en) Treatment of solid particles
GB2219503B (en) Treatment of arthritis
GB8428656D0 (en) Treatment of waste-water
GB2118159B (en) The treatment of aqueous systems
IL70269A0 (en) Composition for the treatment of arthritis
GB2165453B (en) Pharmaceutical agent for the local treatment of psoriasis
DE3568700D1 (en) Anti-ulcer means for the treatment of abscesses
EP0232761A3 (en) Tool for the treatment of surfaces or the like
IE832007L (en) Cyproheptadine treatment of dermatitis.
GB8526645D0 (en) Treatment of surfaces & compositions
DE3266101D1 (en) Process for the preparation of n substituted di and/or polyurethanes
GB2163647B (en) Benzoylecgonie or benzoylnorecgonine as active agent for the treatment of rheumatoid arthritis
GB8428722D0 (en) Treatment of pipelines
GB8501197D0 (en) Treatment of nickel-& vanadium-bearing residues
GB8519733D0 (en) Anticorrosive treatment
GR3000306T3 (en) Composition for the treatment of infections
GB8501617D0 (en) Mechanical treatment of workpieces
EP0190219A4 (en) Composition for the treatment of haemorrhoids.
ZA853759B (en) Tetrahydronaphthalenols for the treatment of hypertension
ZA844311B (en) Improved compositions for the treatment of psoriasis

Legal Events

Date Code Title Description
PE20 Patent expired after termination of 20 years

Effective date: 20040830